In our study, we found that UAP1 gene is amplified in ∼16% of UBC patients in TCGA-BLCA dataset, suggesting another molecular mechanism for the increased UAP1 activity during cancer development. This evidence concerns the gene UAP1 and bladder transitional cell carcinoma.